Dallas Observer2h
Filler Up: Dallas Company Offers a Non-Surgical, 'Down There' Procedure For Men
Men worldwide are getting their "fill" with a new penile enhancement procedure made in Dallas.
CollPlant secures U.S. patent for dermal filler
REHOVOT, Israel - CollPlant Biotechnologies (NASDAQ: CLGN), currently valued at $40.7 million in market capitalization, ...
CollPlant granted patent for photocurable dermal filler product candidate
CollPlant (CLGN) announced it has been granted U.S. Patent No. 12,186,449 related to its photocurable dermal filler product candidate. The ...
Impacts10h
Revitalize Your Look with These Top Cosmetic Restoration Procedures
In today’s world, where appearance often speaks volumes, investing in yourself through cosmetic restoration can be a ...
CollPlant Biotechnologies Provides a Corporate Update
CollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing ...
PE Hub2d
Hildred Capital-backed Crown Laboratories acquires dermal fillers provider Revance Therapeutics
Crown Laboratories, a portfolio company of Hildred Capital, has acquired Revance Therapeutics, a Nashville-based provider of dermal fillers. No financial terms were disclosed. Crown is a Johnson City, ...